Author(s):
Tejaswari Sahu, Vaishnavi Devi, Satya Sai Srinivas Allada, Srinivasa Rao Yarguntla
Email(s):
tejaswarisahu118@gmail.com
DOI:
10.52711/2321-5836.2023.00035
Address:
Tejaswari Sahu1*, Vaishnavi Devi1, Satya Sai Srinivas Allada1, Srinivasa Rao Yarguntla2
1Department of Pharmacy Practice, Vignan Institute of Pharmaceutical Technology, Duvvada, AP, India.
2Department of Pharmaceutics, Vignan Institute of Pharmaceutical Technology, Duvvada, AP, India.
*Corresponding Author
Published In:
Volume - 15,
Issue - 4,
Year - 2023
ABSTRACT:
Acute colonic pseudo-obstruction (ACPO), also known as Ogilvie's syndrome, is a rare but potentially life-threatening condition characterized by a large dilation of the colon without any physical blockage. It predominantly affects elderly individuals with multiple underlying health conditions, postoperative patients, and those receiving medications that impact gastrointestinal motility. The exact underlying mechanisms leading to ACPO remain unclear, but it is believed to result from dysfunction in the autonomic neural system, causing impaired colonic motility. Patients with ACPO typically present with symptoms such as abdominal distension, pain, and constipation. The diagnosis of ACPO is established based on clinical assessment, X-ray imaging, and the exclusion of mechanical obstruction. Treatment for ACPO involves promptly identifying and addressing any underlying medical conditions that may contribute to its development, such as correcting electrolyte imbalances or discontinuing medications with gastrointestinal side effects. Non-invasive measures, such as decompressing the colon using a rectal tube or administering a medication called neostigmine, are often effective in relieving symptoms. In refractory cases where conservative measures fail, surgical intervention may be necessary. Despite the rarity of ACPO, its potential for significant morbidity and mortality emphasizes the importance of promptly recognizing and managing the condition. Healthcare providers should exercise caution in patients with risk factors and clinical features suggestive of ACPO. By understanding the pathophysiology and promptly initiating appropriate interventions, healthcare professionals can optimize outcomes and minimize the potential complications associated with ACPO.
Cite this article:
Tejaswari Sahu, Vaishnavi Devi, Satya Sai Srinivas Allada, Srinivasa Rao Yarguntla. Acute Colonic Pseudo-Obstruction: A Comprehensive Review. Research Journal of Pharmacology and Pharmacodynamics.2023;15(4):198-4. doi: 10.52711/2321-5836.2023.00035
Cite(Electronic):
Tejaswari Sahu, Vaishnavi Devi, Satya Sai Srinivas Allada, Srinivasa Rao Yarguntla. Acute Colonic Pseudo-Obstruction: A Comprehensive Review. Research Journal of Pharmacology and Pharmacodynamics.2023;15(4):198-4. doi: 10.52711/2321-5836.2023.00035 Available on: https://rjppd.org/AbstractView.aspx?PID=2023-15-4-9
REFERENCES:
1. Elsebay L, Galal MA. Ogilvie’s Syndrome after Cesarean Section: Case Report in Saudi Arabia and Management Approach. Case Reports in Obstetrics and Gynecology. 2017; 2017: 1–5.
2. Conner S, Nassereddin A, Mitchell C. Ogilvie Syndrome [Internet]. PubMed. Treasure Island (FL): StatPearls Publishing; 2020 [cited 2020 Nov 29]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK526102/
3. Ogilvie H. Large-intestine Colic due to Sympathetic Deprivation. BMJ. 1948 Oct 9;2(4579):671–3.
4. Wells CI, O’Grady G, Bissett IP. Acute colonic pseudo-obstruction: A systematic review of aetiology and mechanisms. World Journal of Gastroenterology [Internet]. 2017 Aug 14; 23(30): 5634–44. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558126/
5. Haj M, Haj M, Rockey DC. Ogilvie’s syndrome: management and outcomes. Medicine [Internet]. 2018 Jul 6; 97(27). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6076157/
6. Vanek VW, Al-Salti M. Acute pseudo-obstruction of the colon (Ogilvieʼs syndrome). Diseases of the Colon and Rectum. 1986 Mar; 29(3):203–10.
7. Tuyishime E, Grace Mutuyimana M, Zigiranyirazo E, Twagirumugabe T. Case Report of Ogilvie’s Syndrome Following Emergency Haemostatic Sub- total Abdominal Hysterectomy at University Teaching Hospital of Butare, Rwanda. East African Health Research Journal. 2020 Jun 28; 4(1):17–9.
8. Ross SW, Oommen B, Wormer BA, Walters AL, Augenstein VA, Heniford BT, et al. Acute Colonic Pseudo-obstruction: Defining the Epidemiology, Treatment, and Adverse Outcomes of Ogilvie’s Syndrome. The American Surgeon. 2016 Feb; 82(2):102–11.
9. Oh CH, Ji GY, Yoon SH, Hyun D, Park H, Kim YJ. Paralytic Ileus and Prophylactic Gastrointestinal Motility Medication after Spinal Operation. Yonsei Medical Journal [Internet]. 2015 Nov 1; 56(6): 1627–31. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630052/
10. Natalini J, Borno H, Jin L, Jensen T. An unusual manifestation of diabetic ketoacidosis and acute colonic pseudo-obstruction. JRSM Open. 2017 Jun; 8(6):205427041769863.
11. Reeves M, Frizelle F, Wakeman C, Parker C. Acute colonic pseudo-obstruction in pregnancy. ANZ Journal of Surgery. 2015 Jun 4; 85(10):728–33.
12. Saunders MD, Cappell MS. Endoscopic Management of Acute Colonic Pseudo-Obstruction. Endoscopy. 2005 Aug; 37(8):760–3.
13. Jain A, Vargas H. Advances and Challenges in the Management of Acute Colonic Pseudo-Obstruction (Ogilvie Syndrome). Clinics in Colon and Rectal Surgery. 2012 Mar; 25(01):037–45.
14. Saunders MD, Kimmey MB. Systematic review: acute colonic pseudo-obstruction. Alimentary Pharmacology and Therapeutics. 2005 Nov; 22(10):917–25.
15. Gortani G, Pederiva F, Ammar L, Miorin E, Tonin G, Dobbiani G, et al. Ogilvie syndrome in a 8 year old girl after laparoscopic appendectomy. BMC Pediatrics. 2019 Mar 20; 19(1).
16. Pereira P, Djeudji F, Leduc P, Fanget F, Barth X. Ogilvie’s syndrome–acute colonic pseudo-obstruction. Journal of Visceral Surgery [Internet]. 2015 Apr 1 [cited 2021 Dec 3]; 152(2): 99–105. Available from: https://www.sciencedirect.com/science/article/pii/S1878788615000302?via%3Dihub
17. Maloney N, Vargas HD. Acute Intestinal Pseudo-Obstruction (Ogilvie’s Syndrome). Clinics in Colon and Rectal Surgery [Internet]. 2005 May; 18(02): 96–101. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2780141/
18. Tempfer CB, Dogan A, Hilal Z, Rezniczek GA. Acute colonic pseudoobstruction (Ogilvie’s syndrome) in gynecologic and obstetric patients: case report and systematic review of the literature. Archives of Gynecology and Obstetrics. 2019 May 15; 300(1): 117–26.
19. Bhatti ABH, Khan F, Ahmed A. Acute colonic pseudo-obstruction (ACPO) after normal vaginal delivery. JPMA The Journal of the Pakistan Medical Association [Internet]. 2010 Feb 1 [cited 2023 Jan 22]; 60(2): 138–9. Available from: https://pubmed.ncbi.nlm.nih.gov/20209705/
20. De Giorgio R, Knowles CH. Acute colonic pseudo-obstruction. British Journal of Surgery. 2009 Mar; 96(3): 229–39.
21. Jusabani A, Jusabani M, Patel D, Pradhan D, Ramaiya K, Surani S. Ogilvie syndrome: peculiar manifestation of acquired immunodeficiency syndrome (AIDS) in non-institutionalized middle age female in Tanzania. Pan African Medical Journal. 2020; 37.
22. Kotsev S. Ogilvie′s syndrome following cesarean delivery: The Dubai′s case. Saudi Journal of Anaesthesia. 2011; 5(3):335.
23. Sharma R. Visualising the digestive tract: Endoscopy. International Journal of Advances in Nursing Management. 2021; 9(1): 102–3.
24. Yoshimura K, Ohge H, Shimada N, Uegami S, Watadani Y, Nakashima I, et al. Successful surgical procedure based on careful preoperative imaging for chronic idiopathic colonic pseudo-obstruction: a case report. Surgical Case Reports. 2020 Oct 28; 6(1).
25. Ponec RJ, Saunders MD, Kimmey MB. Neostigmine for the Treatment of Acute Colonic Pseudo-Obstruction. New England Journal of Medicine. 1999 Jul 15; 341(3): 137–41.
26. Bresadola V, Brollo PP, Graziano M, Biddau C, Occhiali T, Driul L. The rare Ogilvie’s Syndrome in pregnancy. How to manage? A case report and literature review. Journal of Obstetrics and Gynaecology. 2021 May 2; 42(1): 1–9.
27. Harrison ME, Anderson MA, Appalaneni V, Banerjee S, Ben-Menachem T, Cash BD, et al. The role of endoscopy in the management of patients with known and suspected colonic obstruction and pseudo-obstruction. Gastrointestinal Endoscopy. 2010 Apr; 71(4): 669–79.
28. Valle RGL, Godoy FL. Neostigmine for acute colonic pseudo-obstruction: A meta-analysis. Annals of Medicine and Surgery. 2014 Sep; 3(3): 60–4.
29. Nadukkandiyil N, Alhamad HK, Wahab LA, Al Sulaiti EM, Sankaranarayanan A. Acute intestinal pseudo-obstruction (Ogilvie’s syndrome): A case report. Journal of Clinical Gerontology and Geriatrics. 2014 Dec; 5(4): 140–2.
30. Latunde-Dada AO, Alleemudder DI, Webster DP. Ogilvie’s syndrome following caesarean section. Case Reports. 2013 Jun 19; 2013(jun19 1): bcr2013010013–3.
31. Spira IA, Rodrigues R, Wolff WI. Pseudo-obstruction of the colon. The American Journal of Gastroenterology [Internet]. 1976 May 1 [cited 2023 Jan 25]; 65(5): 397–408. Available from: https://pubmed.ncbi.nlm.nih.gov/949046/
32. Clayman RV, Reddy P, Nivatvongs S. Acute Pseudo-Obstruction of the Colon: A Serious Consequence of Urologic Surgery. Journal of Urology. 1981 Sep; 126(3): 415–7.
33. Dickson MAS, McClure JH. Acute colonic pseudo-obstruction after caesarean section. International Journal of Obstetric Anesthesia. 1994 Oct; 3(4):234–6.
34. De Giorgio R, Barbara G, Stanghellini V, Tonini M, Vasina V, Cola B, et al. The pharmacological treatment of acute colonic pseudo-obstruction. Alimentary Pharmacology and Therapeutics. 2001 Nov 6; 15(11): 1717–27.
35. Eisen GM, Baron TH, Dominitz JA, Faigel DO, Goldstein JL, Johanson JF, et al. Acute colonic pseudo-obstruction. Gastrointestinal Endoscopy. 2002 Dec; 56(6): 789–92.
36. Neely J, Catchpole B. Ileus: The restoration of alimentary-tract motility by pharmacological means. British Journal of Surgery. 1971 Jan; 58(1): 21–8.
37. Aquilonius SM, Hartvig P. Clinical Pharmacokinetics of Cholinesterase Inhibitors. Clinical Pharmacokinetics. 1986; 11(3): 236–49.
38. Sgouros SN. Effect of polyethylene glycol electrolyte balanced solution on patients with acute colonic pseudo obstruction after resolution ofcolonic dilation: a prospective, randomised, placebo controlled trial. Gut. 2006 May 1; 55(5): 638–42.
39. Armstrong DavidN, Ballantyne GarthH, ModlinIrvinM. Erythromycin for reflex ileus in Ogilvie’s syndrome. The Lancet. 1991 Feb; 337(8737): 378.
40. Bonacini M, Smith OJ. Erythromycin as Therapy for Acute Colonic Pseudo-Obstruction (Ogilvieʼs Syndrome). Journal of Clinical Gastroenterology. 1991 Aug; 13(4): 475–6
41. MacColl C, MacCannell KL, Baylis B, Lee SS. Treatment of acute colonic pseudoobstruction (Ogilvie’s syndrome) with cisapride. Gastroenterology. 1990 Mar; 98(3): 773–6.
42. Camilleri M. Tegaserod. Alimentary Pharmacology and Therapeutics. 2001 Mar 6; 15(3): 277–89.
43. Schermer CR, Hanosh JJ, Davis M, Pitcher DE. Ogilvie’s syndrome in the surgical patient: a new therapeutic modality. Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract [Internet]. 1999 [cited 2023 Jan 27]; 3(2): 173–7. Available from: https://pubmed.ncbi.nlm.nih.gov/10457342/
44. Emmanuel AV, Shand AG, Kamm MA. Erythromycin for the treatment of chronic intestinal pseudo-obstruction: description of six cases with a positive response. Alimentary Pharmacology and Therapeutics [Internet]. 2004 Mar 15 [cited 2022 May 7]; 19(6): 687–94. Available from: https://pubmed.ncbi.nlm.nih.gov/15023171/
45. Lee JW, Bang KW, Jang PS, Chung NG, Cho B, Jeong DC, et al. Neostigmine for the treatment of acute colonic pseudo-obstruction (ACPO) in pediatric hematologic malignancies. The Korean Journal of Hematology [Internet]. 2010 Mar 1 [cited 2023 Jan 28]; 45(1): 62–5. Available from: https://pubmed.ncbi.nlm.nih.gov/21120165/
46. Chevallier P, Marcy PY, Francois E, Peten EP, Motamedi JP, Padovani B, et al. Controlled transperitoneal percutaneous cecostomy as a therapeutic alternative to the endoscopic decompression for Ogilvie’s syndrome. The American Journal of Gastroenterology. 2002 Feb; 97(2): 471–4.
47. Ramage JI, Baron TH. Percutaneous endoscopic cecostomy: A case series. Gastrointestinal Endoscopy. 2003 May;57(6):752–5.
48. Vansonnenberg E, Varney RR, Casola G, Macaulay S, Wittich GR, Polansky AM, et al. Percutaneous cecostomy for Ogilvie syndrome: laboratory observations and clinical experience. Radiology. 1990 Jun; 175(3): 679–82.
49. Saunders MD, Cappell MS. Endoscopic Management of Acute Colonic Pseudo-Obstruction. Endoscopy. 2005 Aug; 37(8): 760–3.
50. Kukora JS. Colonoscopic Decompression of Massive Nonobstructive Cecal Dilation. Archives of Surgery. 1977 Apr 1; 112(4): 512.
51. Wegener M, Brsch G. Acute colonic pseudo-obstruction (Ogilvie’s syndrome). Surgical Endoscopy. 1987; 1(3):169–74.